ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Australian State/Territory : QLD
Field of Research : Organic Chemistry
Research Topic : Medical Students
Clear All
Filter by Field of Research
Biological And Medical Chemistry (11)
Organic Chemistry (11)
Organic Chemical Synthesis (10)
Medical Biochemistry: Carbohydrates (3)
Organic Chemistry Not Elsewhere Classified (2)
Oncology And Carcinogenesis (1)
Protein Targeting And Signal Transduction (1)
Separation Science (1)
Synthesis Of Macromolecules (1)
Virology (1)
Filter by Socio-Economic Objective
Treatments (e.g. chemicals, antibiotics) (10)
Chemical sciences (6)
Cancer and related disorders (3)
Infectious diseases (3)
Child health (2)
Plastics in primary forms (2)
Biological sciences (1)
Diagnostics (1)
Immune system and allergy (1)
Prevention—biologicals (e.g. vaccines) (1)
Filter by Funding Provider
Australian Research Council (11)
Filter by Status
Closed (11)
Filter by Scheme
Discovery Projects (5)
Linkage Projects (3)
Linkage Infrastructure, Equipment and Facilities (2)
ARC Centres of Excellence (1)
Filter by Country
Australia (11)
Filter by Australian State/Territory
QLD (11)
NSW (3)
VIC (3)
ACT (2)
  • Researchers (15)
  • Funded Activities (11)
  • Organisations (4)
  • Funded Activity

    Discovery Projects - Grant ID: DP0451795

    Funder
    Australian Research Council
    Funding Amount
    $610,000.00
    Summary
    An Investigation of Novel Sialylmimetics as Inhibitors of Rotavirus. Rotavirus causes severe gastroenteritis in infants worldwide. Over 125 million cases of diarrhoea and 800,000 deaths annually are attributed to rotavirus. The process that enables this debilitating and sometimes fatal disease to infect cells is poorly understood. This project aims to produce a range of unique chemical entities that will provide information about the way rotavirus infects cells. The chemical compounds produc .... An Investigation of Novel Sialylmimetics as Inhibitors of Rotavirus. Rotavirus causes severe gastroenteritis in infants worldwide. Over 125 million cases of diarrhoea and 800,000 deaths annually are attributed to rotavirus. The process that enables this debilitating and sometimes fatal disease to infect cells is poorly understood. This project aims to produce a range of unique chemical entities that will provide information about the way rotavirus infects cells. The chemical compounds produced in this study will be evaluated for their ability to prevent rotavirus from infecting cells. It is expected that this project will provide compounds that may ultimately be used as drugs for the treatment of rotavirus.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP0343302

    Funder
    Australian Research Council
    Funding Amount
    $283,035.00
    Summary
    An Investigation of Novel Sialylmimetics as Inhibitors of Rotavirus. Rotavirus causes severe gastroenteritis in infants worldwide. Over 125 million cases of diarrhoea and 800,000 deaths annually are attributed to rotavirus, primarily in developing countries. The process that enables this debilitating and sometimes fatal disease to infect cells is poorly understood. This project aims to produce a range of unique chemical entities that will provide information about the way rotavirus infects cel .... An Investigation of Novel Sialylmimetics as Inhibitors of Rotavirus. Rotavirus causes severe gastroenteritis in infants worldwide. Over 125 million cases of diarrhoea and 800,000 deaths annually are attributed to rotavirus, primarily in developing countries. The process that enables this debilitating and sometimes fatal disease to infect cells is poorly understood. This project aims to produce a range of unique chemical entities that will provide information about the way rotavirus infects cells. The chemical compounds produced will be assayed for their ability to prevent rotavirus from infecting cells. It is expected that this project will provide compounds that may ultimately be used as drugs for the treatment of rotavirus.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0219286

    Funder
    Australian Research Council
    Funding Amount
    $67,635.00
    Summary
    The development of a rapid diagnostic test for heparanase activity. Heparanase is an enzyme that has been implicated in a number of disease states such as cancer, arthritis, multiple sclerosis and other inflammatory diseases. Characterisation of this enzyme has been slow, due in part to the lack of a reliable direct activity assay. Using a multi-disciplinary approach, this project seeks to establish a rapid assay that will provide easy determination of heparanase activity. Furthermore, this a .... The development of a rapid diagnostic test for heparanase activity. Heparanase is an enzyme that has been implicated in a number of disease states such as cancer, arthritis, multiple sclerosis and other inflammatory diseases. Characterisation of this enzyme has been slow, due in part to the lack of a reliable direct activity assay. Using a multi-disciplinary approach, this project seeks to establish a rapid assay that will provide easy determination of heparanase activity. Furthermore, this assay could provide a useful diagnostic tool in a clinical environment that would allow for the rapid assessment of these diseases, their progression and indeed response to therapy.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0775547

    Funder
    Australian Research Council
    Funding Amount
    $395,354.00
    Summary
    Australian Marine Biodiversity As A Source Of New Drugs To Control Neurodegenerative Disease. With the aging of Australia's population the impact of neurodegenerative diseases such as Alzheimer's and Parkinson's is rapidly on the rise. There is an urgent need to develop new and better drugs to treat the symptoms and underlying cause of these debilitating diseases. Historically, the majority of the world's pharmaceuticals have been drawn from biodiversity (ie plants, microbes and animals). As one .... Australian Marine Biodiversity As A Source Of New Drugs To Control Neurodegenerative Disease. With the aging of Australia's population the impact of neurodegenerative diseases such as Alzheimer's and Parkinson's is rapidly on the rise. There is an urgent need to develop new and better drugs to treat the symptoms and underlying cause of these debilitating diseases. Historically, the majority of the world's pharmaceuticals have been drawn from biodiversity (ie plants, microbes and animals). As one of the few megabiodiverse nations, Australia is ideally positioned to accelerate and focus the search for drugs from nature. This project will explore an exceptionally promising pool of Australian biodiversity, its marine ecosystems, as a source of inspiration for the development of new drugs to treat neurodegenerative diseases.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP0556187

    Funder
    Australian Research Council
    Funding Amount
    $280,000.00
    Summary
    Design and Development of HIV-1 Integrase Inhibitors Based on a Natural Product Lead. HIV/AIDS is a significant health problem with over 40 million people infected with HIV worldwide. Resistance to current drugs is rising rapidly and new therapeutics are urgently needed. This project will bring together local expertise in organic synthesis and virology in order to develop new and better treatments for HIV/AIDS. Ultimately, Australians with HIV may benefit directly from anti-HIV compounds produce .... Design and Development of HIV-1 Integrase Inhibitors Based on a Natural Product Lead. HIV/AIDS is a significant health problem with over 40 million people infected with HIV worldwide. Resistance to current drugs is rising rapidly and new therapeutics are urgently needed. This project will bring together local expertise in organic synthesis and virology in order to develop new and better treatments for HIV/AIDS. Ultimately, Australians with HIV may benefit directly from anti-HIV compounds produced and may also benefit from advances in our understanding of this elusive virus resulting from the project.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP0556268

    Funder
    Australian Research Council
    Funding Amount
    $350,000.00
    Summary
    Anti-Cancer Natural Products: Total Synthesis and Biological Evaluation of Lasonolide A and Analogues. One in three men and one in four women in Australia will be diagnosed with cancer before they reach 75. Cancer is a leading cause of death within this country with 28% of deaths each year due to this disease. Although there have been advances in the treatment of various forms of cancer there remains a pressing need for new therapies with improved potency, selectivity and reduced side effects. T .... Anti-Cancer Natural Products: Total Synthesis and Biological Evaluation of Lasonolide A and Analogues. One in three men and one in four women in Australia will be diagnosed with cancer before they reach 75. Cancer is a leading cause of death within this country with 28% of deaths each year due to this disease. Although there have been advances in the treatment of various forms of cancer there remains a pressing need for new therapies with improved potency, selectivity and reduced side effects. This project will provide new compounds of potential clinical use in the treatment of cancer, thereby aiding the large population of Australians who will be affected by this disease. Furthermore, the new advanced materials produced by this project will aid in the study of biochemical processes involved in cancer.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP0558340

    Funder
    Australian Research Council
    Funding Amount
    $250,000.00
    Summary
    Redox-Tuneable Sensitisers for Photodynamic Therapy of Malignant and Non-Malignant Proliferative Diseases. Cancer is currently Australia's leading cause of death with 85 231 new cases reported during 2000, costing the health system >$2 billion annually. Photodynamic Therapy is a promising anti-cancer therapy which combines the action of a photosensitising drug and light to destroy tumours. This project will lead to the development of new photosensitisers which will enable the specific targeting .... Redox-Tuneable Sensitisers for Photodynamic Therapy of Malignant and Non-Malignant Proliferative Diseases. Cancer is currently Australia's leading cause of death with 85 231 new cases reported during 2000, costing the health system >$2 billion annually. Photodynamic Therapy is a promising anti-cancer therapy which combines the action of a photosensitising drug and light to destroy tumours. This project will lead to the development of new photosensitisers which will enable the specific targeting of tumours while protecting healthy tissue from damage. Post-treatment skin photosensitivity will be minimised by antioxidant features integrated into the photosensitisers. The development of improved photosensitisers during this project will ultimately lead to improved treatment and new alternatives for Australian cancer sufferers.
    Read more Read less
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0883096

    Funder
    Australian Research Council
    Funding Amount
    $600,000.00
    Summary
    Analytical and Preparative Enantioselective Chromatography. Enantiomers are forms of the same molecule that are non-superimposable mirror images of one another, like a left hand and a right hand. Because they are so similar they are very difficult to separate. However, they have very different biological properties, such as when used as drugs. One enantiomer may be beneficial while the other has no effect or sometimes is even toxic. Therefore it is important to be able to tell how much of ea .... Analytical and Preparative Enantioselective Chromatography. Enantiomers are forms of the same molecule that are non-superimposable mirror images of one another, like a left hand and a right hand. Because they are so similar they are very difficult to separate. However, they have very different biological properties, such as when used as drugs. One enantiomer may be beneficial while the other has no effect or sometimes is even toxic. Therefore it is important to be able to tell how much of each enantiomer is present in a sample and to be able to separate them. This facility will allow us to do both of these things.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0560931

    Funder
    Australian Research Council
    Funding Amount
    $225,000.00
    Summary
    Covalent Hydrogen Bond Mimetics of Helical Peptide Hormones. Peptide hormones have been identified that adopt a helical shape when bound to their receptor. The project will produce new versions of these hormones by the use of directly bonded chemical linkers in place of the relatively weak helix hydrogen bonds. The resulting hormone mimics will be more stable, have lower molecular weight and be more selective than the natural hormones making them more suitable as drugs. Our new chemical techn .... Covalent Hydrogen Bond Mimetics of Helical Peptide Hormones. Peptide hormones have been identified that adopt a helical shape when bound to their receptor. The project will produce new versions of these hormones by the use of directly bonded chemical linkers in place of the relatively weak helix hydrogen bonds. The resulting hormone mimics will be more stable, have lower molecular weight and be more selective than the natural hormones making them more suitable as drugs. Our new chemical techniques allow us for the first time to fully investigate this approach which if successful will be applicable to many other helical peptides and therefore could be an important drug development technique.
    Read more Read less
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0233459

    Funder
    Australian Research Council
    Funding Amount
    $136,000.00
    Summary
    High Pressure Chemistry Facility. High pressure is a mild, clean and high yielding method of promoting a variety of important chemical reactions. This proposal seeks equipment to conduct such reactions on a pilot and large scale or in large numbers (high-pressure combinatorial chemistry). This equipment would be unique in the Southern Hemsiphere and, together with existing infrastructure, creates an Australian centre in high pressure, liquid - phase chemistry. It would support research programm .... High Pressure Chemistry Facility. High pressure is a mild, clean and high yielding method of promoting a variety of important chemical reactions. This proposal seeks equipment to conduct such reactions on a pilot and large scale or in large numbers (high-pressure combinatorial chemistry). This equipment would be unique in the Southern Hemsiphere and, together with existing infrastructure, creates an Australian centre in high pressure, liquid - phase chemistry. It would support research programmes aimed at developing new materials for microelectronic components and new compounds for high through-put drug discovery and insecticide discovery programmes.
    Read more Read less
    More information

    Showing 1-10 of 11 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback